Divergent Pro- and Antiinflammatory Roles for IL-23 and IL-12 in Joint Autoimmune Inflammation
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
Interleukin (IL) 23 is a heterodimeric cytokine composed of a p19 subunit and the p40 subunit of IL-12. IL-23 affects memory T cell and inflammatory macrophage function through engagement of a novel receptor (IL-23R) on these cells. Recent analysis of the contribution of IL-12 and IL-23 to central nervous system autoimmune inflammation demonstrated that IL-23 rather than IL-12 was the essential cytokine. Using gene-targeted mice lacking only IL-12 (p35−/−) or IL-23 (p19−/−), we show that the specific absence of IL-23 is protective, whereas loss of IL-12 exacerbates collagen-induced arthritis. IL-23 gene-targeted mice did not develop clinical signs of disease and were completely resistant to the development of joint and bone pathology. Resistance correlated with an absence of IL-17–producing CD4+ T cells despite normal induction of collagen-specific, interferon-γ–producing T helper 1 cells. In contrast, IL-12–deficient p35−/− mice developed more IL-17–producing CD4+ T cells, as well as elevated mRNA expression of proinflammatory tumor necrosis factor, IL-1β, IL-6, and IL-17 in affected tissues of diseased mice. The data presented here indicate that IL-23 is an essential promoter of end-stage joint autoimmune inflammation, whereas IL-12 paradoxically mediates protection from autoimmune inflammation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




![Figure 5. A model proposing the respective roles of IL-12/IFN-γ and IL-23 in T cell-priming events versus end-stage autoimmune inflammation. The precise mechanism through which IL-12/IFN-γ may down-regulate the magnitude of the inflammatory response (i.e., reducing IL-17 production) remains to be defined. It is recognized that IFN-γ may have dual roles during late-stage inflammation (i.e., antiinflammatory actions through termination of activated T cell responses [references 9, 29] while also stimulating macrophage function [reference 5]). a, The IL-23R is present on CD4+ CD45RBlo “memory” T cells (30), but this cell phenotype may also include activated CD4+ T cells that are not strictly memory T cells.](https://figures.cochat.ai/paper-figures/7aaa8df7955d4b7f85c0b7ac367626a2/divergent-pro-and-antiinflammatory-roles-for-il-23-and-il-12-in-joint-autoimmune-figure-5.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Th17 cells, originally described in mice as being pathogenic in murine models of autoimmune disease [181, 182], have more recently been shown to protect against certain pathogens, including fungal infections [183].”
From Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition) (2021) · cites this paper as [182]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cua, D. J., Sherlock, J., Chen, Y., Murphy, C. A., Joyce, B., Seymour, B., Lucian, L., To, W., Kwan, S., Churakova, T., et al. (2003) · Nature · doi:10.1038/nature01355 · Cited by 2,906
Self-citationOppmann, B., Lesley, R., Blom, B., Timans, J. C., Xu, Y., Hunte, B., Vega, F., Yu, N., Wang, J., Singh, K., et al. (2000) · Immunity · doi:10.1016/s1074-7613(00)00070-4 · Cited by 2,822
Self-citationAggarwal, S., Ghilardi, N., Xie, M.-H., de Sauvage, F. J., & Gurney, A. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207577200 · Cited by 1,847
Parham, C., Chirica, M., Timans, J., Vaisberg, E., Travis, M., Cheung, J., Pflanz, S., Zhang, R., Singh, K. P., Vega, F., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.11.5699 · Cited by 1,296
Self-citationRapid and coordinated switch in chemokine receptor expression during dendritic cell maturation
Sallusto, F., Schaerli, P., Loetscher, P., Schaniel, C., Lenig, D., Mackay, C. R., Qin, S., & Lanzavecchia, A. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199809)28:09<2760::aid-immu2760>3.0.co;2-n · Cited by 1,183
Immunisation against heterologous type II collagen induces arthritis in mice
Courtenay, J. S., Dallman, M. J., Dayan, A. D., Martin, A., & Mosedale, B. (1980) · Nature · doi:10.1038/283666a0 · Cited by 1,025
Luster, A. D., Unkeless, J. C., & Ravetch, J. V. (1985) · Nature · doi:10.1038/315672a0 · Cited by 944
Willenborg, D. O., Fordham, S., Bernard, C. C., Cowden, W. B., & Ramshaw, I. A. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.8.3223 · Cited by 635
Ziolkowska, M., Koc, A., Luszczykiewicz, G., Ksiezopolska-Pietrzak, K., Klimczak, E., Chwalinska-Sadowska, H., & Maslinski, W. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.5.2832 · Cited by 580 · cited 1×
“IL-17 is a potent proinflammatory cytokine produced by PBMCs/T cells and by cells isolated from synovial fluid of rheumatoid arthritis patients (27).”
BackgroundAccelerated collagen-induced arthritis in IFN-gamma receptor-deficient mice
Vermeire, K., Heremans, H., Vandeputte, M., Huang, S., Billiau, A., & Matthys, P. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.11.5507 · Cited by 458
Cited by
Items 501–600 of 1,001
Platt, A. M., Gibson, V. B., Patakas, A., Benson, R. A., Nadler, S. G., Brewer, J. M., McInnes, I. B., & Garside, P. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001311 · Cited by 96
Immunological Cells and Functions in Gaucher Disease
Pandey, M. K., & Grabowski, G. A. (2013) · Critical Reviews in Oncogenesis · doi:10.1615/critrevoncog.2013004503 · Cited by 96
A tale of two cytokines: IL-17 and IL-22 in asthma and infection
Manni, M. L., Robinson, K. M., & Alcorn, J. F. (2013) · Expert Review of Respiratory Medicine · doi:10.1586/17476348.2014.854167 · Cited by 102
TNF blockade requires 1,25(OH)2D3 to control human Th17-mediated synovial inflammation
van Hamburg, J. P., Asmawidjaja, P. S., Davelaar, N., Mus, A. M. C., Cornelissen, F., van Leeuwen, J. P. T. M., Hazes, J. M. W., Dolhain, R. J. E. M., Bakx, P. A. G. M., Colin, E. M., et al. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-200424 · Cited by 103
Brembilla, N. C., Montanari, E., Truchetet, M.-E., Raschi, E., Meroni, P., & Chizzolini, C. (2013) · Arthritis Research & Therapy · doi:10.1186/ar4334 · Cited by 95
Th17 cells in autoimmune demyelinating disease
Segal, B. M. (2010) · Seminars in Immunopathology · doi:10.1007/s00281-009-0186-z · Cited by 103
IL-23 signaling enhances Th2 polarization and regulates allergic airway inflammation
Peng, J., Yang, X. O., Chang, S. H., Yang, J., & Dong, C. (2009) · Cell Research · doi:10.1038/cr.2009.128 · Cited by 105
Liu, F.-L., Chen, C.-H., Chu, S., Chen, J.-H., Lai, J., Sytwu, H., & Chang, D. (2007) · Rheumatology · doi:10.1093/rheumatology/kem055 · Cited by 95
The Mucosal Immune System and Its Regulation by Autophagy
Kabat, A. M., Pott, J., & Maloy, K. J. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00240 · Cited by 92
Cytokine inhibitors in rheumatoid arthritis and other autoimmune diseases
Williams, R. O., Paleolog, E. M., & Feldmann, M. (2007) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2007.06.001 · Cited by 108
Advances in the pathogenesis and treatment of IBD
Braus, N. A., & Elliott, D. E. (2009) · Clinical Immunology · doi:10.1016/j.clim.2009.02.006 · Cited by 101
IL-23 Is Required for Neutrophil Homeostasis in Normal and Neutrophilic Mice
Smith, E. E., Zarbock, A., Stark, M. A., Burcin, T. L., Bruce, A. C., Foley, P. L., & Ley, K. F. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.12.8274 · Cited by 102
Menegatti, S., Bianchi, E., & Rogge, L. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00382 · Cited by 100
Autoimmunity: IL‐21: a new player in Th17‐cell differentiation
Deenick, E. K., & Tangye, S. G. (2007) · Immunology and Cell Biology · doi:10.1038/sj.icb.7100114 · Cited by 93
Ustekinumab: Lessons Learned from Targeting Interleukin‐12/23p40 in Immune‐Mediated Diseases
Elliott, M., Benson, J., BLANK, M. A., Brodmerkel, C. M., Baker, D., Sharples, K. R., & Szapary, P. O. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05070.x · Cited by 101
Th17 cells: critical mediators of host responses to burn injury and sepsis
Rendón, J. L., & Choudhry, M. A. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.0212083 · Cited by 106
Desmoglein 3–specific CD4+ T cells induce pemphigus vulgaris and interface dermatitis in mice
Takahashi, H., Kouno, M., Nagao, K., Wada, N. A., Hata, T., Nishimoto, S., Iwakura, Y., Yoshimura, A., Yamada, T., Kuwana, M., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57379 · Cited by 96
Impact of cytokines and T lymphocytes upon osteoclast differentiation and function
Gillespie, M. T. (2007) · Arthritis Research & Therapy · doi:10.1186/ar2141 · Cited by 94
MicroRNA-155 Confers Encephalogenic Potential to Th17 Cells by Promoting Effector Gene Expression
Hu, R., Huffaker, T. B., Kagele, D. A., Runtsch, M. C., Bake, E., Chaudhuri, A. A., Round, J. L., & O’Connell, R. M. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300351 · Cited by 92
Kurebayashi, Y., Nagai, S., Ikejiri, A., & Koyasu, S. (2013) · Genes to Cells · doi:10.1111/gtc.12039 · Cited by 104
From Inflammation to Cancer in Inflammatory Bowel Disease: Molecular Perspectives.
Romano, M., Francesco, F. D., Zarantonello, L., Ruffolo, C., Ferraro, G. A., Zanus, G., Giordano, A., Bassi, N., & Cillo, U. (2016) · PubMed · Cited by 105
Cho, J. J., Xu, Z., Parthasarathy, U., Drashansky, T. T., Helm, E. Y., Zuniga, A. N., Lorentsen, K. J., Mansouri, S., Cho, J. Y., Edelmann, M. J., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-08605-3 · Cited by 98
Targeting the development and effector functions of TH17 cells
Ghilardi, N., & Ouyang, W. (2007) · Seminars in Immunology · doi:10.1016/j.smim.2007.10.016 · Cited by 106
Selective abrogation of Th1 response by STA-5326, a potent IL-12/IL-23 inhibitor
Wada, Y., Lu, R., Zhou, D., Chu, J., Przewloka, T., Zhang, S., Li, L., Wu, Y., Qin, J., Balasubramanyam, V., et al. (2006) · Blood · doi:10.1182/blood-2006-04-019398 · Cited by 99
Yeremenko, N. G., Paramarta, J. E., & Baeten, D. (2014) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000069 · Cited by 104
Kimura, A., & Kishimoto, T. (2010) · International Immunopharmacology · doi:10.1016/j.intimp.2010.10.004 · Cited by 102
Schinnerling, K., Rosas, C., Soto, L., Thomas, R., & Aguillón, J. C. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00203 · Cited by 101
Baker, D. A., Barth, J., Chang, R., Obeid, L. M., & Gilkeson, G. S. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000644 · Cited by 91
Magyari, L., Varszegi, D., Kovesdi, E., Sarlos, P., Farago, B., Javorhazy, A., Sumegi, K., Banfai, Z., & Melegh, B. (2014) · World Journal of Orthopedics · doi:10.5312/wjo.v5.i4.516 · Cited by 105
IL-12 Contributes to Allergen-Induced Airway Inflammation in Experimental Asthma
Meyts, I., Hellings, P. W., Hens, G., Vanaudenaerde, B. M., Verbinnen, B., Heremans, H., Matthys, P., Bullens, D. M., Overbergh, L., Mathieu, C., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.9.6460 · Cited by 89
Wozniak, T. M., Ryan, A. A., & Britton, W. J. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.12.8684 · Cited by 92
Human T helper type 1 dichotomy: origin, phenotype and biological activities
Annunziato, F., Cosmi, L., Liotta, F., Maggi, E., & Romagnani, S. (2015) · Immunology · doi:10.1111/imm.12399 · Cited by 107
da Rocha, L. F., Duarte, Â. L. B. P., Dantas, A. T., Mariz, H. D. A., Pitta, I. D. R., Galdino, S. L., & Pitta, M. G. D. R. (2012) · The Journal of Rheumatology · doi:10.3899/jrheum.111027 · Cited by 93
Intranasal Immunization Promotes Th17 Immune Responses
Zygmunt, B. M., Rharbaoui, F., Groebe, L., & Guzmán, C. A. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901144 · Cited by 94
Inflammation and liver tumorigenesis
Sun, B., & Karin, M. (2013) · Frontiers of Medicine · doi:10.1007/s11684-013-0256-4 · Cited by 97
Do studies in humans better depict Th17 cells?
Annunziato, F., & Romagnani, S. (2009) · Blood · doi:10.1182/blood-2009-03-209189 · Cited by 99
Imbalance between Th17 and regulatory T-cells in systemic lupus erythematosus
Kleczyńska, W., Jakieła, B., Plutecka, H., Milewski, M., Sanak, M., & Musiał, J. (2012) · Folia Histochemica et Cytobiologica · doi:10.5603/fhc.2011.0088 · Cited by 94
Chyuan, I., & Lai, J. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.113928 · Cited by 91
Organizing structural principles of the IL-17 ligand–receptor axis
Wilson, S. C., Caveney, N. A., Yen, M., Pollmann, C., Xiang, X., Jude, K. M., Hafer, M., Tsutsumi, N., Piehler, J., & Garcia, K. C. (2022) · Nature · doi:10.1038/s41586-022-05116-y · Cited by 84
Mensah‐Brown, E. P. K., Shahin, A., Al‐Shamisi, M., Wei, X., & Lukić, M. L. (2005) · European Journal of Immunology · doi:10.1002/eji.200535325 · Cited by 92
Human Th17 cells in infection and autoimmunity
Sallusto, F., & Lanzavecchia, A. (2009) · Microbes and Infection · doi:10.1016/j.micinf.2009.04.004 · Cited by 94
The role of T helper type 17 cells in inflammatory arthritis
Sarkar, S., Cooney, L. A., & Fox, D. A. (2009) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2009.04016.x · Cited by 96
Rao, D. A., Eid, R. E., Qin, L., Yi, T., Kirkiles-Smith, N. C., Tellides, G., & Pober, J. S. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20081661 · Cited by 86
Flk-1+ mesenchymal stem cells aggravate collagen-induced arthritis by up-regulating interleukin-6
Chen, B., Hu, J., Liao, L., Sun, Z., Han, Q., Song, Z.-C., & Zhao, R. C. (2009) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2009.04069.x · Cited by 89
Enigma of IL-17 and Th17 Cells in Rheumatoid Arthritis and in Autoimmune Animal Models of Arthritis
Kugyelka, R., Kohl, Z., Olasz, K., Mikecz, K., Rauch, T. A., Glant, T. T., & Boldizsár, F. (2016) · Mediators of Inflammation · doi:10.1155/2016/6145810 · Cited by 102
Mise‐Omata, S., Kuroda, E., Niikura, J., Yamashita, U., Obata, Y., & Doi, T. S. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.10.6596 · Cited by 86
Día, V. P., Bringe, N. A., & de Mejía, E. G. (2013) · Food Chemistry · doi:10.1016/j.foodchem.2013.11.155 · Cited by 95
STAT3: An Important Regulator of Multiple Cytokine Functions
Stepkowski, S. M., Chen, W., Ross, J. A., Nagy, Z. S., & Kirken, R. A. (2008) · Transplantation · doi:10.1097/tp.0b013e3181739d25 · Cited by 86
Update on cytokines in rheumatoid arthritis
Brennan, F. M., & Beech, J. T. (2007) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e32805e87f1 · Cited by 94
Wu, Y., Mingliang, R., Yang, R., Liang, X., Ma, Y., Tang, Y., Huang, L. C., Ye, J., Chen, K., Wang, P., et al. (2011) · Arthritis Research & Therapy · doi:10.1186/ar3257 · Cited by 88
RetractedKrausz, S., Boumans, M. J. H., Gerlag, D. M., Lufkin, J., van Kuijk, A. W. R., Bakker, A., de Boer, M., Lodde, B. M., Reedquist, K. A., Jacobson, E. W., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34339 · Cited by 85
Parasitic Helminths: New Weapons against Immunological Disorders
Osada, Y., & Kanazawa, T. (2010) · Journal of Biomedicine and Biotechnology · doi:10.1155/2010/743758 · Cited by 87
Zhou, L., Shi, Y., Li, K., Hamzavi, I. H., Gao, T., Huggins, R. H., Lim, H. W., & Mi, Q. (2015) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12355 · Cited by 86
T-bet is a key modulator of IL-23-driven pathogenic CD4+ T cell responses in the intestine
Krausgruber, T., Schiering, C., Adelmann, K., Harrison, O. J., Chomka, A., Pearson, C., Ahern, P. P., Shale, M., Oukka, M., & Powrie, F. (2016) · Nature Communications · doi:10.1038/ncomms11627 · Cited by 86
Li, J., Wei, H., Krystek, S. R., Bond, D., Brender, T., Cohen, D., Feiner, J., Hamacher, N. B., Harshman, J., Huang, R. Y. ‐., et al. (2017) · Analytical Chemistry · doi:10.1021/acs.analchem.6b03058 · Cited by 91
Liu, W. (2010) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2010.10.004 · Cited by 103
Brentano, F., Ospelt, C., Stańczyk, J., Gay, R. E., Gay, S., & Kyburz, D. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.082081 · Cited by 96
Schinnerling, K., Aguillón, J. C., Catalán, D., & Soto, L. (2017) · Clinical & Experimental Immunology · doi:10.1111/cei.12966 · Cited by 90
Targeting IL-17 and Th17 Cells in Rheumatoid Arthritis
Sarkar, S., & Fox, D. A. (2010) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2010.02.006 · Cited by 89
Granucci, F., Foti, M., & Ricciardi‐Castagnoli, P. (2005) · Advances in immunology · doi:10.1016/s0065-2776(05)88006-x · Cited by 97
Breaking old paradigms: Th17 cells in autoimmune arthritis
Peck, A., & Mellins, E. (2009) · Clinical Immunology · doi:10.1016/j.clim.2009.03.522 · Cited by 94
Immunological and Antitumor Effects of IL-23 as a Cancer Vaccine Adjuvant
Overwijk, W. W., de Visser, K. E., Tirion, F. H., de Jong, L. A., Pols, T. W. H., van der Velden, Y. U., van den Boorn, J. G., Keller, A. M., Buurman, W. A., Theoret, M. R., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.9.5213 · Cited by 85
Self-citationYoshiga (1998) · International Journal of Molecular Medicine · doi:10.3892/ijmm_00000032 · Cited by 83
TGF-β, a 'double agent' in the immune pathology war
Cua, D. J., & Kastelein, R. A. (2006) · Nature Immunology · doi:10.1038/ni0606-557 · Cited by 83
Self-citationYeilding, N. M., Szapary, P. O., Brodmerkel, C. M., Benson, J., Plotnick, M. I., Zhou, H., Goyal, K., Schenkel, B., Giles-Komar, J. M., Mascelli, M. A., et al. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.05963.x · Cited by 86
Hong, T., Xing, J., Li, L., & Tyson, J. J. (2011) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002122 · Cited by 89
Basso, A. S., Cheroutre, H., & Mucida, D. (2009) · Cell Research · doi:10.1038/cr.2009.26 · Cited by 104
B Cell Chemoattractant CXCL13 Is Preferentially Expressed by Human Th17 Cell Clones
Takagi, R., Higashi, T., Hashimoto, K., Nakano, K., Mizuno, Y., Okazaki, Y., & Matsushita, S. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.1.186 · Cited by 81
Sun, X., Minohara, M., Kikuchi, H., Ishizu, T., Tanaka, M., Piao, H. Z., Osoegawa, M., Ohyagi, Y., Shimokawa, H., & Kira, J. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.06.027 · Cited by 80
Clinical implication of recent advances in our understanding of IL-17 and reproductive immunology
Saito, S., Nakashima, A., Ito, M., & Shima, T. (2011) · Expert Review of Clinical Immunology · doi:10.1586/eci.11.49 · Cited by 84
Emerging cytokine targets in rheumatoid arthritis
Asquith, D. L., & McInnes, I. B. (2007) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e3280eec78c · Cited by 88
Mazzoni, A., Santarlasci, V., Maggi, L., Capone, M., Rossi, M. C., Querci, V., De Palma, R., Chang, H.-D., Thiel, A., Cimaz, R., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1401303 · Cited by 79
Ma, D., Zhu, X., Zhao, P., Zhao, C., Li, X., Zhu, Y., Li, L.-Z., Sun, J., Peng, J., Ji, C., et al. (2008) · Annals of Hematology · doi:10.1007/s00277-008-0535-3 · Cited by 79
Li, R.-R., Pang, L., Du, Q., Shi, Y., Dai, W., & Kai-sheng, Y. (2010) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923970903420566 · Cited by 83
Human mast cells capture, store, and release bioactive, exogenous IL-17A
Noordenbos, T., Blijdorp, I. C. J., Chen, S., Stap, J., Mul, E. P. J., Cañete, J. D. D., Lubberts, E., Yeremenko, N. G., & Baeten, D. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.3hi1215-542r · Cited by 87
Mini Review: New Treatments in Psoriatic Arthritis. Focus on the IL-23/17 Axis
Sakkas, L. I., Zafiriou, E., & Bogdanos, D. P. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00872 · Cited by 85
Natural killer cells in inflammatory autoimmune diseases
Yang, Y., Day, J. A., Souza-Fonseca-Guimarães, F., Wicks, I. P., & Louis, C. (2021) · Clinical & Translational Immunology · doi:10.1002/cti2.1250 · Cited by 86
Th17 Cells in Inflammatory Conditions
Cooke, A. (2006) · The Review of Diabetic Studies · doi:10.1900/rds.2006.3.72 · Cited by 78
Non-Canonical Notch Signaling Drives Activation and Differentiation of Peripheral CD4+ T Cells
Dongre, A., Surampudi, L., Lawlor, R. G., Fauq, A. H., Miele, L., Golde, T. E., Minter, L. M., & Osborne, B. A. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00054 · Cited by 90
van Hamburg, J. P., Mus, A.-M. C., de Bruijn, M. J. W., de Vogel, L., Boon, L., Cornelissen, F., Asmawidjaja, P. S., Hendriks, R. W., & Lubberts, E. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24329 · Cited by 83
Marijnissen, R. J., Koenders, M. I., Smeets, R. L., Stappers, M. H. T., Nickerson‐Nutter, C. L., Joosten, L. A. B., Boots, A. M. H., & van den Berg, W. B. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30469 · Cited by 84
Inhibiting RORγt/Th17 axis for autoimmune disorders
Isono, F., Fujita-Sato, S., & Ito, S. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.04.012 · Cited by 82
Gulen, M. F., Bulek, K., Xiao, H., Yu, M., Gao, J., Sun, L., Beurel, E., Kaidanovich-Beilin, O., Fox, P. L., DiCorleto, P. E., et al. (2012) · Immunity · doi:10.1016/j.immuni.2012.08.019 · Cited by 75
Elevated expression of IL-17 and IL-12 genes in chronic inflammatory periodontal disease
Honda, T., Aoki, Y., Takahashi, N., Maekawa, T., Nakajima, T. E., Ito, H., Tabeta, K., Okui, T., Kajita, K., Domon, H., et al. (2008) · Clinica Chimica Acta · doi:10.1016/j.cca.2008.06.003 · Cited by 82
Chadha, R., Heidt, S., Jones, N. D., & Wood, K. J. (2011) · Transplantation · doi:10.1097/tp.0b013e3182126eeb · Cited by 75
Implications of anti-cytokine therapy in colorectal cancer and autoimmune diseases
Wang, K., Grivennikov, S. I., & Karin, M. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-202201 · Cited by 80
Mus, A. M. C., Cornelissen, F., Asmawidjaja, P. S., van Hamburg, J. P., Boon, L., Hendriks, R. W., & Lubberts, E. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27336 · Cited by 82
T helper 17 cells: discovery, function, and physiological trigger
Torchinsky, M. B., & Blander, J. M. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0248-3 · Cited by 92
Chackerian, A. A., Chen, S.-J., Brodie, S. J., Mattson, J. D., McClanahan, T. K., Kastelein, R. A., & Bowman, E. P. (2006) · Infection and Immunity · doi:10.1128/iai.00621-06 · Cited by 74
Self-citationFunctional Relevance of the IL-23–IL-17 Axis in Lungs In Vivo
Ivanov, S., Bozinovski, S., Bossios, A., Valadi, H., Vlahos, R., Malmhäll, C., Sjöstrand, M., Kolls, J. K., Anderson, G. P., & Lindén, A. (2006) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2006-0020oc · Cited by 84
T helper cell effector fates — who, how and where?
Reinhardt, R. L., Kang, S., Liang, H.-E., & Locksley, R. M. (2006) · Current Opinion in Immunology · doi:10.1016/j.coi.2006.03.003 · Cited by 97
Oyamada, A., Ikebe, H., Itsumi, M., Saiwai, H., Okada, S., Shimoda, K., Iwakura, Y., Nakayama, K. I., Iwamoto, Y., Yoshikai, Y., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0902740 · Cited by 80
Signal transduction and Th17 cell differentiation
O'Shea, J. J., Steward-Tharp, S. M., Laurence, A., Watford, W. T., Wei, L., Adamson, A. S., & Fan, S. (2009) · Microbes and Infection · doi:10.1016/j.micinf.2009.04.007 · Cited by 73
Microbial-Induced Th17: Superhero or Supervillain?
McGeachy, M. J., & McSorley, S. J. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201834 · Cited by 74
Th17 cells in autoimmune diseases
Han, L., Yang, J. C., Wang, X., Li, D., Lv, L., & Li, B. (2015) · Frontiers of Medicine · doi:10.1007/s11684-015-0388-9 · Cited by 92
Targeting Interleukin-23 in the Treatment of Noninfectious Uveitis
Pepple, K. L., & Lin, P. (2018) · Ophthalmology · doi:10.1016/j.ophtha.2018.05.014 · Cited by 75
The IL-12 Cytokine and Receptor Family in Graft-vs.-Host Disease
Bastian, D. A., Wu, Y., Betts, B. C., & Yu, X. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00988 · Cited by 78
Sobiś, J., Rykaczewska-Czerwińska, M., Świętochowska, E., & Gorczyca, P. W. (2014) · Pharmacological Reports · doi:10.1016/j.pharep.2014.09.007 · Cited by 79
Differentiation and function of pro-inflammatory Th17 cells
Dong, C. (2009) · Microbes and Infection · doi:10.1016/j.micinf.2009.04.001 · Cited by 81
Correa, F., Hernangómez, M., Mestre, L., Loría, F., Docagne, F., & Guaza, C. (2011) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2011.01.020 · Cited by 82
Metadata
- Authors
- Murphy, C. A., Langrish, C. L., Chen, Y., Blumenschein, W., McClanahan, T., Kastelein, R. A., Sedgwick, J. D., & Cua, D. J.
- Affiliations
- 1Discovery Research, DNAX Research Inc., Palo Alto, CA 94304
- 2Experimental Pathology and Pharmacology, DNAX Research Inc., Palo Alto, CA 94304
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2003-12-08
- Volume
- 198
- Issue
- 12
- Pages
- 1951-1957
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC2194162
- OpenAlex
- W2116828514
- Cited by
- 1,669
- References
- 32
- Citations by year
- 2026: 18 · 2025: 14 · 2024: 27 · 2023: 31 · 2022: 34 · 2021: 42 · 2020: 46 · 2019: 53 · 2018: 53 · 2017: 56 · 2016: 55 · 2015: 76 · 2014: 75 · 2013: 98 · 2012: 105
- FWCI
- 15.13
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- cc-by-nc-sa
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- IL-23, IL-12, collagen-induced arthritis, IL-17-producing T cells, CD4+ T cells, Th1 cells, IL23R, bone pathology, inflammatory cytokines, TNF-α, IL-1β, interleukin-6, IL-17
- MeSH terms
- Animals, Arthritis, Experimental, Female, Interferon-gamma, Interleukins, Male, Mice, Inbred C57BL, T-Lymphocytes, Tumor Necrosis Factor-alpha, Interleukin-12, Interleukin-17, Collagen Type II, Mice, Interleukin-23, Interleukin-23 Subunit p19
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.